{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid2o6ghllx6o6qotttw4xdohbxmue7kjjy73qm35465jt2mue3w4u",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhhztdjc37d2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia42tpapencv25bl4hucrblkgkan76mmy7p4jhd7juo34xt5yrgga"
    },
    "mimeType": "image/jpeg",
    "size": 102613
  },
  "path": "/2026/03/19/eli-lilly-retatrutide-in-vivo-cart-readout-newsletter/?utm_campaign=rss",
  "publishedAt": "2026-03-19T14:10:40.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research",
    "STAT+"
  ],
  "textContent": "Eli Lilly's 'triple-G' drug shows potency, In-vivo CAR-T inches toward clinical reality, and more in today's Readout newsletter.",
  "title": "STAT+: Eli Lilly’s ‘triple-G’ shows potency, raises concerns",
  "updatedAt": "2026-03-19T14:10:45.000Z"
}